Patent ID: 7618654

Claim:
A method of providing myeloid cells to a patient in need thereof, said method comprising the step of transplanting into said patient a composition comprising common myeloid progenitor cells or their lineage-restricted descendents, wherein the portion of said composition consisting of common myeloid progenitor cells or their lineage-restricted descendents is prepared prior to being added to said composition by the method of combining reagents that specifically recognize Thy-1, IL-7Rα (CD127), and a lineage panel, wherein said lineage panel is selected from the group consisting of CD2; CD3; CD4; CD7; CD8; CD10; CD11b; CD14; CD19; CD20; CD56; and glycophorin A (GPA), with a sample of hematopoietic cells; and selecting for those cells that are Thy-1 − , IL-7Rα (CD127) − , and lacking expression of markers in the lineage panel, to provide an enriched population of common myeloid progenitor cells or their lineage-restricted descendents.